Particle Data Platform

Vaccine economics don’t pencil out

55:3555:52 · 17s

Bret and Heather walk through an AI-aided back-of-the-envelope analysis suggesting an mRNA hantavirus vaccine isn’t commercially viable without government purchase and liability shields.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.